2019
DOI: 10.1002/jmri.26887
|View full text |Cite
|
Sign up to set email alerts
|

Differentiating Parkinson's disease motor subtypes using automated volume‐based morphometry incorporating white matter and deep gray nuclear lesion load

Abstract: Background Periventricular leukoaraiosis may be an important pathological change in postural instability gait disorder (PIGD), a motor subtype of Parkinson's disease (PD). Clinical diagnosis of PIGD may be challenging for the general neurologist. Purpose To evaluate 1) the utility of a fully automated volume‐based morphometry (Vol‐BM) in characterizing imaging diagnostic markers in PD and PIGD, including, 2) novel deep gray nuclear lesion load (GMab), and 3) discriminatory performance of a Vol‐BM model constru… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
9
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(10 citation statements)
references
References 36 publications
1
9
0
Order By: Relevance
“…These results suggest that the rs11240572-A variant may slow down the progression of PD, consistent with previous reports suggesting that it has a protective function (Chang et al, 2013;Tan et al, 2010;Yan et al, 2011). The pathogenesis of PD involves the basal ganglia, including the caudate nucleus and putamen, resulting in impaired movement control (Fang et al 2020) as well as poor cognition such as impaired learning, planning, memory, and emotion (Obeso et al, 2008;Gao et al, 2017). Previous studies have found that PD patients have a variable GMV in the putamen, caudate nucleus, cerebellum and cerebral cortex.…”
Section: Discussionsupporting
confidence: 91%
“…These results suggest that the rs11240572-A variant may slow down the progression of PD, consistent with previous reports suggesting that it has a protective function (Chang et al, 2013;Tan et al, 2010;Yan et al, 2011). The pathogenesis of PD involves the basal ganglia, including the caudate nucleus and putamen, resulting in impaired movement control (Fang et al 2020) as well as poor cognition such as impaired learning, planning, memory, and emotion (Obeso et al, 2008;Gao et al, 2017). Previous studies have found that PD patients have a variable GMV in the putamen, caudate nucleus, cerebellum and cerebral cortex.…”
Section: Discussionsupporting
confidence: 91%
“…Furthermore, increased thalamic and GP volumes found in TD suggest this regional enlargement indicates that TD are initially protected from a damaged basal ganglia‐thalamocortical circuitry and could potentially explain why the TD subtype does not experience PIGD symptoms associated with BG degeneration 26 . These results are further supported by a recent lesion study showing PIGD patients have higher novel deep gray nuclear lesion load in the caudate compared to non‐PIGD and healthy controls (HC) 56 . GM analysis appears to support current PD circuitry models that underlie motor subtype differentiation of neuronal loss in key relay nuclei and stands as a valuable tool in the diagnostics and evaluation of PD subtypes.…”
Section: Resultsmentioning
confidence: 61%
“…When TD patients were compared to PIGD, PIGD patients were associated with additional degradations of white matter such as higher leukoaraiosis grade 53, 55 . More recently, when compared to non‐PIGD and HC, PIGD patients showed a significantly higher white matter lesion (WML) load 56 . In reference 27, researchers also showed PIGD to have higher WML volume compared to TD while reference 57 showed PIGD exhibited more WM degradation relative to TD.…”
Section: Resultsmentioning
confidence: 99%
“…Previous studies investigating the impact of MRI measures on cognitive and motor symptoms in PD have mostly been cross sectional in their WMH and GM assessments ( Zeighami et al, 2015 , Dadar et al, 2018a , de Schipper et al, 2019 , Toda et al, 2019 , Stojkovic et al, 2018 , Dadar, et al, 2020 , Zeighami et al, 2017 , Fang et al, 2020 , Wan et al, 2019 ), are mainly from the Parkinson's Progression Markers Initiative (PPMI) study which includes only de novo PD patients at baseline ( Zeighami et al, 2015 , Zeighami et al, 2019 , Dadar et al, 2018a , Dadar, et al, 2020 , Zeighami et al, 2017 , Chahine et al, 2019 ), and most don’t assess the impact of grey matter and white matter measures in the same setting ( Zeighami et al, 2015 , Zeighami et al, 2019 , de Schipper et al, 2019 , Pozorski et al, 2019 , Toda et al, 2019 , Stojkovic et al, 2018 , Dadar, et al, 2020 , Zeighami et al, 2017 , Wan et al, 2019 , Chahine et al, 2019 ). In comparison, there are several strengths to the present study.…”
Section: Discussionmentioning
confidence: 99%